Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative fluorescence imaging with cRGD-ZW800-1 for oral cancer surgery
NL-OMON24301Not yet recruiting
- Sponsor
- Erasmus MC
- Start
- Jan 2020
- Modality
- Peptide-Drug Conjugates → Peptide Conjugates → Peptides
- Countries
- 1
01
Overview
Open-label trial of cRGD-ZW800-1 in Oral Mucosal Carcinoma (2 cohorts), sponsored by Erasmus MC. Primary endpoints: Mean tumor-to-background ratio and Rate of adequate tumor resection margins. Planned start Jan 2020; status: not yet recruiting.
02
Drugs
cRGD-ZW800-1
03
Conditions
Oral Mucosal Carcinoma
Beyond the preview
Go deeper on NL-OMON24301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24301.